Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

AstraZeneca partners with Chinese firm ahead of next obesity race
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market.   5 February 2026
LSPN Awards USA returns for second year—with new categories
Americas
LSPN Awards USA returns for second year—with new categories
Nominations are open for the Life Sciences Patent Network's 2026 awards in Boston, including six new categories and winners selected by leading industry experts.   3 February 2026
Drowning in EU regulations? Five tips for surviving the deluge of new rules
Europe
Drowning in EU regulations? Five tips for surviving the deluge of new rules
As legislative activity in life sciences increases, in-house teams are struggling to keep up. Experts share their sources and strategies for monitoring developments, coordinating internally, and knowing when to engage.   3 February 2026
Careers
Moderna VP and regulatory expert moves to private practice
The third European life sciences hire in recent months brings in-house regulatory expertise from Moderna in Munich.   2 February 2026
Careers
Pearce IP grows practice with senior patent hire
Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as demand for specialist patent services rises.   29 January 2026
Americas
Sanofi suffers setback in insulin monopoly dispute
A judge has allowed antitrust claims against the pharma giant to move forward, finding that it plausibly used bundled rebates and patent abuse to extend its insulin monopoly, though one allegation was dismissed.   29 January 2026
Careers
Firm adds seven-lawyer team in second major merger
New York-based firm makes its second key acquisition in weeks, as the firm pursues growth by broadening its litigation capabilities.   29 January 2026
Americas
Fed Circ overturns PTAB decision in $83.4m DNA case
The court found the board applied the wrong legal standard when evaluating Guardant Health’s obviousness challenge to a University of Washington DNA sequencing patent.   26 January 2026
Americas
Novartis win blocks generics relitigating $7.8bn heart drug patent
A district court judge shuts down a Novartis rival from reopening validity and infringement arguments over an Entresto patent.   22 January 2026
Careers
Cadwalader global head among trio moving to Orrick
Orrick, Herrington & Sutcliffe adds senior litigators with experience in patent, trade secret, copyright, trademark, and commercial disputes across life sciences and technology.   22 January 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.